What we eat can influence our immune health, but could our earliest experiences with food shape how well our bodies fight infections later in life?
A new study published in Nature Immunology suggests that exposure to a high fat diet during pregnancy or early life may affect how the immune system develops. Researchers at the University of Pennsylvania found that mice exposed to such diets had weaker responses to vaccination, with some effects persisting even after the dietary exposure ended. Whether the same thing happens in humans remains unknown.
The findings suggest that early life may be an especially important period for immune development. Researchers compared mice exposed to a high fat diet before birth or shortly afterward with mice receiving a standard diet. They found differences in the development of immune cells that help the body produce antibodies, which are essential for protection against infections.
Those differences mattered when the mice were vaccinated. The high fat diet group showed weaker responses in parts of the immune system responsible for building antibody protection.
Perhaps most interestingly, the changes appeared to persist. When researchers transferred immune cells from the affected mice into other mice eating a standard diet, those cells still struggled to develop normally.
Timing also made a difference. Similar high fat dietary exposure beginning in adulthood did not produce the same immune-cell impairment, suggesting that the developing immune system may be particularly sensitive to early nutritional conditions.
"Maternal and early postnatal diet create an environmental signal that can durably reprogram developing T cells," said Jorge Henao-Mejia, a professor at the University of Pennsylvania and senior author of the study.
Researchers also identified a gene called A20 that appeared to play an important role in these changes. Restoring its activity in affected mouse immune cells improved their development, raising questions about whether some of the effects might eventually be reversible.
To investigate whether the findings could be relevant to people, the researchers examined immune cells from five patients with a rare genetic condition affecting A20. They found similar differences in immune-cell development, but these patients were not studied because of their diets or weight. The human findings therefore do not establish that high-fat diets weaken children's immune systems.
There are other important limitations. The mice consumed a diet containing 60% of calories from fat, and researchers could not fully separate the effects of the diet from those of obesity. The study also did not determine whether the mice were more likely to develop infections or whether these changes would persist throughout their lives.
For now, the research offers new insight into how early nutrition might influence immune development, rather than specific dietary recommendations. It does not suggest that eating fat during pregnancy harms a child's immunity or that children with obesity cannot respond effectively to vaccines.
The study received support from the National Institutes of Health, Children's Hospital of Philadelphia, the Burroughs Wellcome Fund, the Chan Zuckerberg Initiative and other organizations. One researcher disclosed patents and advisory relationships involving mRNA vaccine technology. Other authors reported biotechnology consulting relationships.
